Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LANCELOT-ACS: Atopaxar in Non-ST-Elevation Acute Coronary Syndrome
NCT00548587Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of atopaxar in acute coronary syndrome (ACS), sponsored by Eisai Co., Ltd.. Started Oct 2007; status: completed.
02
Drugs
atopaxar
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00548587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548587.